Stephen Royle
Director/Board Member at The Company of Biologists Ltd.
Stephen Royle active positions
| Companies | Position | Start | End |
|---|---|---|---|
The Company of Biologists Ltd.
 The Company of Biologists Ltd. Miscellaneous Commercial ServicesCommercial Services The Company of Biologists Ltd. is a not-for-profit publishing organization that supports and inspires the biological community. The non-profit company is based in Histon, UK. The British company is run by distinguished practicing scientists and exist to profit science, not shareholders. The company publishes leading peer-reviewed journals such as Development, Journal of Cell Science, and Journal of Experimental Biology. The company offers a range of resources to early-career researchers and have chosen the 'transformative' route towards Open Access. The company promotes the use of Caenorhabditis elegans to investigate ten of the 14 cancer hallmarks that define the mechanisms of cancer. | Director/Board Member | - | - |
Career history of Stephen Royle
Statistics
International
| United Kingdom | 2 |
Operational
| Director/Board Member | 1 |
Sectoral
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
The Company of Biologists Ltd.
The Company of Biologists Ltd. Miscellaneous Commercial ServicesCommercial Services The Company of Biologists Ltd. is a not-for-profit publishing organization that supports and inspires the biological community. The non-profit company is based in Histon, UK. The British company is run by distinguished practicing scientists and exist to profit science, not shareholders. The company publishes leading peer-reviewed journals such as Development, Journal of Cell Science, and Journal of Experimental Biology. The company offers a range of resources to early-career researchers and have chosen the 'transformative' route towards Open Access. The company promotes the use of Caenorhabditis elegans to investigate ten of the 14 cancer hallmarks that define the mechanisms of cancer. | Commercial Services |
- Stock Market
- Insiders
- Stephen Royle
- Experience
